Pneumococcal Infections

• EMA approval · 2026-07-16
  EMA Authorised: Vaxneuvance (pneumococcal polysaccharide conjugate vaccine (adsorbed)) — Merck Sharp & Dohme B.V.

  EMA authorises Vaxneuvance (pneumococcal polysaccharide conjugate vaccine, adsorbed) for pneumococcal infections.

• EMA approval · 2026-01-06
  EMA Authorised: Vaxneuvance (pneumococcal polysaccharide conjugate vaccine (adsorbed)) — Merck Sharp & Dohme B.V.

  The European Medicines Agency authorised Merck's Vaxneuvance, a pneumococcal polysaccharide conjugate vaccine (adsorbed), for pneumococcal i…

• EMA approval · 2025-11-18
  EMA Authorised: Prevenar 20 (previously Apexxnar) (Pneumococcal polysaccharide serotype 1;Pneumococcal polysaccharide serotype 3;Pneumococcal polysaccharide serotype 4;Pneumococcal polysaccharide serotype 5;Pneumococcal polysaccharide serotype 6A;Pneumococcal polysaccharide serotype 6B;Pneumococcal polysaccharide serotype 7F;Pneumococcal polysaccharide serotype 8;Pneumococcal polysaccharide serotype 9V;Pneumococcal polysaccharide serotype 10A;Pneumococcal polysaccharide serotype 11A;pneumococcal polysaccharide serotype 12F;Pneumococcal polysaccharide serotype 14;Pneumococcal polysaccharide serotype 15b;Pneumococcal polysaccharide serotype 18C;Pneumococcal polysaccharide serotype 19A;Pneumococcal polysaccharide serotype 19F;Pneumococcal polysaccharide serotype 22F;Pneumococcal polysaccharide serotype 23F;Pneumococcal polysaccharide serotype 33F) — Pfizer Europe MA EEIG

  The EMA authorised Prevenar 20 (formerly Apexxnar), a 20-valent pneumococcal conjugate vaccine by Pfizer, for vaccination against pneumococc…

• EMA approval · 2025-10-06
  EMA Authorised: Capvaxive (pneumococcal polysaccharide serotype 3, 6A, 7F, 8, 9N, 10A, 11A, 12F, 15A, 15B de-O-acetylated, 16F, 17F, 19A, 20A, 22F, 23A, 23B, 24F, 31, 33F and 35B conjugated to CRM197 carrier protein) — Merck Sharp & Dohme B.V.

  EMA has authorised Capvaxive, a pneumococcal conjugate vaccine covering multiple serotypes and developed by Merck Sharp & Dohme B.V., for pr…

• EMA approval · 2023-05-24
  EMA Authorised: Synflorix (Pneumococcal polysaccharide serotype 23F;Pneumococcal polysaccharide serotype 4;Pneumococcal polysaccharide serotype 5;Pneumococcal polysaccharide serotype 6B;Pneumococcal polysaccharide serotype 7F;Pneumococcal polysaccharide serotype 9V;Pneumococcal polysaccharide serotype 1;Pneumococcal polysaccharide serotype 14;Pneumococcal polysaccharide serotype 18C;Pneumococcal polysaccharide serotype 19F) — GlaxoSmithKline Biologicals S.A.

  EMA has authorised Synflorix, a pneumococcal conjugate vaccine by GlaxoSmithKline Biologicals S.A., for immunization against multiple pneumo…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.